p53 ubiquitination: Mdm2 and beyond
- PMID: 16455486
- PMCID: PMC3737769
- DOI: 10.1016/j.molcel.2006.01.020
p53 ubiquitination: Mdm2 and beyond
Abstract
Although early studies have suggested that the oncoprotein Mdm2 is the primary E3 ubiquitin ligase for the p53 tumor suppressor, an increasing amount of data suggests that p53 ubiquitination and degradation are more complex than once thought. The discoveries of MdmX, HAUSP, ARF, COP1, Pirh2, and ARF-BP1 continue to uncover the multiple facets of this pathway. There is no question that Mdm2 plays a pivotal role in downregulating p53 activities in numerous cellular settings. Nevertheless, growing evidence challenges the conventional view that Mdm2 is essential for p53 turnover.
Figures
Similar articles
-
Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.Mol Biol Rep. 2011 Jan;38(1):229-36. doi: 10.1007/s11033-010-0099-x. Epub 2010 Mar 24. Mol Biol Rep. 2011. PMID: 20333547
-
Dynamics in the p53-Mdm2 ubiquitination pathway.Cell Cycle. 2004 Jul;3(7):895-9. Epub 2004 Jul 2. Cell Cycle. 2004. PMID: 15254415 Review.
-
Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.FEBS Lett. 2009 Sep 3;583(17):2710-4. doi: 10.1016/j.febslet.2009.07.021. Epub 2009 Jul 18. FEBS Lett. 2009. PMID: 19619542
-
MDMX Recruits UbcH5c to Facilitate MDM2 E3 Ligase Activity and Subsequent p53 Degradation In Vivo.Cancer Res. 2021 Feb 15;81(4):898-909. doi: 10.1158/0008-5472.CAN-20-0790. Epub 2020 Dec 4. Cancer Res. 2021. PMID: 33277368 Free PMC article.
-
ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation.Cell Cycle. 2005 Sep;4(9):1166-70. doi: 10.4161/cc.4.9.1981. Epub 2005 Sep 29. Cell Cycle. 2005. PMID: 16082221 Review.
Cited by
-
Critical role of presenilin-dependent γ-secretase activity in DNA damage-induced promyelocytic leukemia protein expression and apoptosis.Cell Death Differ. 2013 Apr;20(4):639-48. doi: 10.1038/cdd.2012.162. Epub 2013 Jan 11. Cell Death Differ. 2013. PMID: 23306558 Free PMC article.
-
Downregulation of cyclin D1 sensitizes cancer cells to MDM2 antagonist Nutlin-3.Oncotarget. 2016 May 31;7(22):32652-63. doi: 10.18632/oncotarget.8999. Oncotarget. 2016. PMID: 27129163 Free PMC article.
-
Augmented BMP signaling in the neural crest inhibits nasal cartilage morphogenesis by inducing p53-mediated apoptosis.Development. 2015 Apr 1;142(7):1357-67. doi: 10.1242/dev.118802. Epub 2015 Mar 5. Development. 2015. PMID: 25742798 Free PMC article.
-
HUWE1 interacts with PCNA to alleviate replication stress.EMBO Rep. 2016 Jun;17(6):874-86. doi: 10.15252/embr.201541685. Epub 2016 May 4. EMBO Rep. 2016. PMID: 27146073 Free PMC article.
-
Cooperation between oncogenic Ras and wild-type p53 stimulates STAT non-cell autonomously to promote tumor radioresistance.Commun Biol. 2021 Mar 19;4(1):374. doi: 10.1038/s42003-021-01898-5. Commun Biol. 2021. PMID: 33742110 Free PMC article.
References
-
- Adams MD, Celnkier SE, Holt RA, Evans CA, Gocayne JD, Amanatides PG, Scherer SE, Li PW, Hoskins RA, Galle RF, et al. The genome sequence of Drosophila melanogaster. Science. 2000;287:2185–2195. - PubMed
-
- Adhikary S, Marinoni F, Hock A, Hulleman E, Popov N, Beier R, Bernard S, Quarto M, Capra M, Goettig S, et al. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell. 2005;123:409–421. - PubMed
-
- Bernards A, Hariharan IK. Of flies and men–studying human disease in Drosophila. Curr. Opin. Genet. Dev. 2001;11:274–278. - PubMed
-
- Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell. 2004;119:591–602. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous